The RPH Group’s mission is to promote the quality of life of the population through technology applied to health. We seek to be the leading brand in the supply of products and services for diagnosis and treatment in the Latin American market, and we value quality, credibility, integrity, teamwork, sustainable growth and exceeding the expectations of our customers and end consumers.
We deliver complete solutions for doctors, clinics and hospitals, in Nuclear Medicine, through our three business units.
Pharmaceutical industry that produces and commerciallize Cold Kits – lyophilized reagent kits. Injectable drugs or radiopharmaceuticals that, when complexed with radiation, allow visualizing the physiological processes in a non-invasive way using appropriate imaging equipment.
RPH CENTRAL PHARMA
Centralized Radiopharmacy that manipulates and distributes to the services of Nuclear Medicine, by medical prescription, individual doses of radiopharmaceuticals ready for administration in patients.